ArticleACS pharmacology & translational science2022

Validating the Arrhythmogenic Potential of High-, Intermediate-, and Low-Risk Drugs in a Human-Induced Pluripotent Stem Cell-Derived Cardiac Microphysiological System.

Verena Charwat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.